BFM
TXMD icon

Boothbay Fund Management’s TherapeuticsMD TXMD Stock Holding History

Boothbay Fund Management’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-325
Closed -$26K – 1422
2020
Q3 		$26K Sell
325
-2,895
-90% -$231K ﹤0.01% 1008
2020
Q2 		$201K Buy
+3,220
New +$187K 0.01% 798
2020
Q1 		– Sell
-836
Closed -$101K – 1066
2019
Q4 		$101K Buy
+836
New +$120K 0.01% 758
2016
Q4 		– Sell
-611
Closed -$208K – 941
2016
Q3 		$208K Buy
+611
New +$223K 0.05% 547

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Boothbay Fund Management's TXMD Position: Q4 2020 in Review

Boothbay Fund Management sold out of TherapeuticsMD (TXMD) in Q4 2020, closing a stake of 325 shares — an estimated $26K sold.

Boothbay Fund Management first reported a position in TXMD in Q3 2016 and held it in 4 quarters. The position peaked at $208K in Q3 2016. 159 funds tracked by Wall St. Rank hold TXMD as of Q4 2020.

  • Boothbay Fund Management reported no remaining TherapeuticsMD position as of Q4 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 325 TherapeuticsMD shares in Q4 2020, an estimated $26K.
  • Boothbay Fund Management first reported a position in TherapeuticsMD in Q3 2016 and held it in 4 quarters.
  • Boothbay Fund Management's TherapeuticsMD position peaked at $208K in Q3 2016.
  • 159 funds tracked by Wall St. Rank held TherapeuticsMD as of Q4 2020.

Based on Boothbay Fund Management's 13F filing for Q4 2020, filed 12 Feb 2021.